Definitive Contract 75F40122C00104

The Department of Health and Human Services' Food and Drug Administration awarded a $157,134 firm fixed price delivery order contract to Regan Technologies Corporation. This order is placed against Solutions for Enterprise-Wide Procurement V, a government-wide acquisition contract vehicle, to provide CLC BIO software licenses. The place of performance is Silver Spring, Maryland. The one-year contract begins on September 27, 2023 and concludes on September 29, 2024. As the FDA works to protect...

This is a $165,457 firm-fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Global Life Sciences Solutions USA LLC, a for-profit limited liability company. The contract is for the delivery of mechanistic chromatography modeling software. This award is not associated with a set-aside program. Through this contract, the FDA is acquiring scientific software to support its biomedical research and laboratory operations. Global Life Sciences Solutions USA LLC is...

<p>The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price Purchase Order contract to Chemsw, Inc., a small business, for the annual licensing fee for the CHEMSW ICMS LIVE 5 USERS software system. The contract has a ceiling value of $3,937.50 and a period of performance ending on September 15, 2012. This contract is a standalone award and not associated with a larger vehicle.</p>

The Department of Health and Human Services' Food and Drug Administration awarded a $611,141 firm fixed price definitive contract to Clarivate Analytics (Us) LLC for a Cortellis Clinical Trials software license. Under this contract, Clarivate Analytics will provide its Cortellis Clinical Trials software to support the FDA's clinical research programs. No major subcontractors or set aside designations were identified. The Cortellis Clinical Trials software will be licensed for use at the FDA's...

The U.S. Food and Drug Administration (FDA) awarded a firm fixed price purchase order to Certara UK Limited, doing business as Certara, a for-profit limited liability company, for SIMCYP software licenses and maintenance support. The $114,316.00 contract will allow the FDA's Office of Clinical Pharmacology Drug Reviewers to complete their review of investigational new drugs. Certara has previously provided this physiologically-based pharmacokinetic modeling software to the FDA and...

The Department of Health and Human Services Food and Drug Administration awarded a $207,623 purchase order to Clarivate Analytics (Us) LLC for ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURER DATA ACQUISITION. Under this firm fixed price contract, Clarivate Analytics will provide data acquisition services to the FDA relating to API manufacturers. Performance will take place in Silver Spring, Maryland over approximately one year, from September 2023 through September 2024. As the regulator of...

The Food and Drug Administration has awarded a firm-fixed price delivery order worth $20,652.66 to Blue TECH Inc. for Poly Clariti software licenses. This acquisition was conducted under Federal Acquisition Regulation Part 16.5 for indefinite-delivery contracts. The contract has a total small business set aside designation and requires delivery by December 19, 2024. Blue TECH is a small business certified as woman-owned and as a HUBZone firm. The company provides a wide range of information...

This $227,480 firm fixed price purchase order was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Clarivate Analytics (Us) LLC, a global provider of scientific research databases and analytics platforms. The contract is for data acquisition services related to active pharmaceutical ingredient (API) manufacturing, with a completion date of September 24, 2023. Clarivate Analytics, a foreign-owned for-profit company, has held multiple indefinite...

The Department of Health and Human Services' Food and Drug Administration awarded a $43,243.20 firm fixed price purchase order to Certara USA Inc. for SEND EXPLORER licenses. The place of performance is Silver Spring, Maryland. The one-year contract runs from September 12, 2023 through September 14, 2024. Certara USA Inc. will provide the FDA with software licenses to support the agency's regulatory science and public health protection missions. No subcontractors or set asides were identified....

The U.S. Food and Drug Administration (FDA) awarded a $1,485,010.00 definitive, firm-fixed-price contract to Spectral Platforms Inc., a minority-owned, for-profit organization. The contract, with a completion date of September 22, 2026, is for a comprehensive toxicity analysis of individual end flavor ingredient chemicals, both alone and in complex with metals, using high-throughput approaches. This contract does not have a set-aside designation. Spectral Platforms Inc. is the prime...